Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
04/18/17 PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition 33
04/17/17 8-K Current report filing
Documents
5
04/03/17 8-K Current report filing
Documents
11
04/03/17 10-K Annual report pursuant to Section 13 and 15(d) 92
04/03/17 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT 3
03/23/17 424B3 Prospectus filed pursuant to Rule 424(b)(3) 7
03/22/17 8-K Current report filing
Documents
6
03/14/17 8-K Current report filing
Documents
29
02/28/17 8-K Current report filing
Documents
28
02/23/17 8-K Current report filing
Documents
5
RSS